TrialNature communications2026

Bispecific GLP-1/GLP-2 agonism in advanced type 2 diabetes: preclinical characterization and a randomized, double-blind, placebo-controlled phase I trial.

Sang-In Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.